PerkinElmer receives notice CDPH to end Valencia Lab contract on May 15, 2022; reaffirms $400M+ COVID revenue in 2022

REVVITY, INC.

CDPH to end contract for supply and operation of Valencia Branch Laboratory effective May 15, 2022 due to decrease in COVID cases.
Company reiterates expectation of at least $400 million aggregate COVID-related revenue in 2022.
Further update to be provided on Q1 2022 earnings call.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.